Seite 1 von 59 Asthma Leitlinie: Referenzen [www.evidence.de ...

Asthma Leitlinie: Referenzen [www.evidence.de] evidenzbasierte Leitlinien
597.Turner, E. S., Greenberger, P. A., and Patterson, R., Management of the pregnant asthmatic patient. Ann
Intern Med, 1980. 93(6): p. 905-18.
Evidenzklasse: IV
Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6778281
598.Turner, M. O., et al., Risk factors for near-fatal asthma. A case-control study in hospitalized patients with
asthma. Am J Respir Crit Care Med, 1998. 157(6 Pt 1): p. 1804-9.
Evidenzklasse: III
Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9620909
599.Turner, M. O., et al., A randomized trial comparing peak expiratory flow and symptom self- management
plans for patients with asthma attending a primary care clinic. Am J Respir Crit Care Med, 1998. 157(2): p.
540-6.
Evidenzklasse: Ib
Link: http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.ajrccm.org/cgi/content/full/157/2/540
600.Udwadia, Z. F. and Harrison, B. D., An attempt to determine the optimal duration of hospital stay following
a severe attack of asthma. J R Coll Physicians Lond, 1990. 24(2): p. 112-4.
Evidenzklasse: III
Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2352195
601.Ukena, D., et al., [Therapy of nocturnal asthma: salmeterol versus nocturnal administration of retard
theophylline--comparison of effectiveness and tolerance]. Pneumologie, 1997. 51(3): p. 317-23.
Evidenzklasse: Ib
Link:
602.Ulrik, C. S., et al., Risk factors for development of asthma in children and adolescents: findings from a
longitudinal population study. Respir Med, 1996. 90(10): p. 623-30.
Evidenzklasse: III
Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8959120
603.van der Heide, S., et al., Clinical effects of air cleaners in homes of asthmatic children sensitized to pet
allergens. J Allergy Clin Immunol, 1999. 104(2 Pt 1): p. 447-51.
Evidenzklasse: Ib
Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10452769
604.van der Molen, T., et al., Starting with a higher dose of inhaled corticosteroids in primary care asthma
treatment. Am J Respir Crit Care Med, 1998. 158(1): p. 121-5.
Evidenzklasse: Ib
Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9
655717
605.van der Molen, T., et al., Effects of the long acting beta agonist formoterol on asthma control in asthmatic
patients using inhaled corticosteroids. The Netherlands and Canadian Formoterol Study Investigators. Thorax,
1997. 52(6): p. 535-9.
Evidenzklasse: Ib
Link:
606.Van Ganse, E., et al., Effects of antihistamines in adult asthma: a meta-analysis of clinical trials. Eur
Respir J, 1997. 10(10): p. 2216-24.
Evidenzklasse: Ia
Link:
607.van Grunsven, P. M., et al., Compliance during long-term treatment with fluticasone propionate in subjects
with early signs of asthma or chronic obstructive pulmonary disease (COPD): results of the Detection,
Intervention, and Monitoring Program of COPD and Asthma (DIMCA) Study. J Asthma, 2000. 37(3): p. 225-34.
Evidenzklasse: Ib
http://www.evidence.de/Leitlinien/leitlinien-intern/Asthma_Start/Asthma_Referenzen...
Seite 54 von 59
09.07.2005